Comparison of diagnostic values of haematological and inflammatory parameters in predicting COPD exacerbation

1. Mirza S, Clay RD, Koslow MA, Scanlon PD. COPD guidelines: A review of the 2018 GOLD Report. Mayo Clin Proc. 2018;93(10): 1488–1502.10.1016/j.mayocp.2018.05.02630286833Search in Google Scholar

2. Barbu C, Iordache M, Man MG. Inflammation in COPD: Pathogenesis, local and systemic effects. Rom J Morphol Embryol. 2011;52(1): 21–27.Search in Google Scholar

3. Wouters EF, Groenewegen KH, Dentener MA, Vernooy JH. Systemic inflammation in chronic obstructive pulmonary disease: The role of exacerbations. Proc Am Thorac Soc. 2007;4(8): 626–634.10.1513/pats.200706-071TH18073394Search in Google Scholar

4. Koutsokera A, Stolz D, Loukides S, Kostikas K. Systemic biomarkers in exacerbations of COPD: The evolving clinical challenge. Chest. 2012;141(2): 396–3405.10.1378/chest.11-049521835899Search in Google Scholar

5. Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10(2): 81–89.10.1513/AnnalsATS.201208-043OC23607835Search in Google Scholar

6. Hoenderdos K, Condliffe A. The neutrophil in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2013;48(5): 531–539.10.1165/rcmb.2012-0492TR23328639Search in Google Scholar

7. Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1): 16–27.10.1016/j.jaci.2016.05.01127373322Search in Google Scholar

8. Zhou X, Li Q, Zhou X. Exacerbation of chronic obstructive pulmonary disease. Cell Biochem Biophys. 2015;73(2): 349–355.10.1007/s12013-015-0605-9709237527352322Search in Google Scholar

9. Pascual-Gonzalez Y, Lopez-Sanchez M, Dorca J, Santos S. Defining the role of neutrophil-to-lymphocyte ratio in COPD: A systematic literature review. Int J Chron Obstruct Pulmon Dis. 2018;13: 3651–3662.10.2147/COPD.S178068622585430464448Search in Google Scholar

10. Bialas AJ, Pedone C, Piotrowski WJ, Incalzi RA. Platelet distribution width as a prognostic factor in patients with COPD - pilot study. Int J Chron Obstruct Pulmon Dis. 2017;12: 2261–2267.10.2147/COPD.S131868554658828814854Search in Google Scholar

11. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: A systematic review and meta-analysis. J Thromb Haemost. 2010;8(1): 148–156.10.1111/j.1538-7836.2009.03584.x375549619691485Search in Google Scholar

12. Biljak VR, Pancirov D, Cepelak I, Popovic-Grle S, Stjepanovic G, Grubisic TZ. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease. Platelets. 2011;22(6): 466–470.10.3109/09537104.2011.57388721506665Search in Google Scholar

13. Steiropoulos P, Papanas N, Nena E, Xanthoudaki M, Goula T, Froudarakis M, et al. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: The role of comorbidities. Angiology. 2013;64(7): 535–539.10.1177/000331971246143623052724Search in Google Scholar

14. Kony S, Zureik M, Driss F, Neukirch C, Leynaert B, Neukirch F. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): A population based study. Thorax. 2004;59(10): 892–896.10.1136/thx.2003.015768174682815454657Search in Google Scholar

15. Dentener MA, Creutzberg EC, Schols AM, Mantovani A, Veer CV, Buurman WA, et al. Systemic anti-inflammatory mediators in COPD: Increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax. 2001;56(9): 721–726.10.1136/thx.56.9.721Search in Google Scholar

16. Burge S, Wedzicha JA. COPD exacerbations: Definitions and classifications. Eur Respir J. 2003;21(41 suppl): 46s–53s.10.1183/09031936.03.0007800212795331Search in Google Scholar

17. Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(12): 1298–1303.10.1164/rccm.200310-1443OC14990395Search in Google Scholar

18. Rodriguez-Roisin R. COPD exacerbations 5: Management. Thorax. 2006;61(6): 535–544.10.1136/thx.2005.041863211121916738044Search in Google Scholar

19. Soler-Cataluna JJ, Martinez-Garcia MA, Sanchez PR, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11): 925–931.10.1136/thx.2005.040527174723516055622Search in Google Scholar

20. Tanriverdi H, Ornek T, Erboy F, Altinsoy B, Uygur F, Atalay F, et al. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD. Wien Klin Wochenschr. 2015;127(19): 756–763.10.1007/s00508-014-0690-625586444Search in Google Scholar

21. In E, Kuluozturk M, Oner O, Deveci F. The importance of neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease. Turk Thorac J. 2016;17(2): 41–46.10.5578/ttj.17.2.009579211529404122Search in Google Scholar

22. Gunay E, Ulasli SS, Akar O, Ahsen A, Gunay S, Koyuncu T, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: A retrospective study. Inflammation. 2014;37(2): 374–380.10.1007/s10753-013-9749-124078279Search in Google Scholar

23. Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I. Platelet distribution width: A simple, practical and specific marker of activation of coagulation. Hippokratia. 2010;14(1): 28–32.Search in Google Scholar

24. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1): 47–58.10.2174/13816121179504980421247392Search in Google Scholar

25. Agapakis DI, Massa EV, Hantzis I, Maraslis S, Alexiou E, Imprialos KP, et al. The role of mean platelet volume in chronic obstructive pulmonary disease exacerbation. Respir Care. 2016;61(1): 44–49.10.4187/respcare.0413226604328Search in Google Scholar

26. Wang RT, Li JY, Cao ZG, Li Y. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease. Respirology. 2013;18(8): 1244–1248.10.1111/resp.1214323786593Search in Google Scholar

27. Ulasli SS, Ozyurek BA, Yilmaz EB, Ulubay G. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Pol Arch Med Wewn. 2012;122(6): 284–290.10.20452/pamw.128422576316Search in Google Scholar

28. Makhlouf HA, Sadek SH, Nafady AA. Platelet function in diabetic and nondiabetic patients with chronic obstructive pulmonary disease: A case control study. Clin Respir J. 2018;12(1): 48–56.10.1111/crj.1247727003100Search in Google Scholar

29. Bansal R, Gupta HL, Goel A, Yadav M. Association of increased platelet volume in patients of chronic obstructive pulmonary disease: Clinical implications. J Indian Acad Clin Med. 2002;3(2): 169–172.Search in Google Scholar

30. Bessman JD, Williams LJ, Gilmer PR, Jr. Platelet size in health and hematologic disease. Am J Clin Pathol. 1982;78(2): 150–153.10.1093/ajcp/78.2.1506954850Search in Google Scholar

31. Yohannes AM, Ershler WB. Anemia in COPD: A systematic review of the prevalence, quality of life, and mortality. Respir Care. 2011;56(5): 644–652.10.4187/respcare.0100221276321Search in Google Scholar

32. Gunen H, Hacievliyagil SS, Kosar F, Mutlu LC, Gulbas G, Pehlivan E, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J. 2005;26(2): 234–241.10.1183/09031936.05.0002480416055870Search in Google Scholar

33. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124(2): 459–467.10.1378/chest.124.2.45912907529Search in Google Scholar

34. Shafiek H, Abd-elwahab N, Baddour M, Degady A, El-hoffy M. Outcome predictors of severe acute exacerbation of chronic obstructive pulmonary disease: Role of inflammatory biomarkers. Int J Respir Pulm Med. 2016;3(2): 047.10.23937/2378-3516/1410047Search in Google Scholar